ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
-0.01%
Bitcoin
67,604.38
0.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) News

VIR

Vir Biotechnology (VIR)

Vir Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VIR
DateTimeSourceHeadlineSymbolCompany
05/31/20241:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
05/31/20241:42PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
05/29/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
05/29/20243:05PMBusiness WireVir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:VIRVir Biotechnology Inc
05/29/20247:05AMBusiness WireVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical OfficerNASDAQ:VIRVir Biotechnology Inc
05/23/20243:05PMBusiness WireVir Biotechnology to Host 2024 Annual Meeting of StockholdersNASDAQ:VIRVir Biotechnology Inc
05/22/20247:05AMBusiness WireMultiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024NASDAQ:VIRVir Biotechnology Inc
05/21/20247:17AMBusiness WireVir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024NASDAQ:VIRVir Biotechnology Inc
05/14/20243:05PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VIRVir Biotechnology Inc
05/02/20243:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
04/30/20243:05PMBusiness WireVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024NASDAQ:VIRVir Biotechnology Inc
04/18/20247:00AMBusiness WireVir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of DirectorsNASDAQ:VIRVir Biotechnology Inc
04/11/20243:30PMBusiness WireVir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:VIRVir Biotechnology Inc
03/05/20247:05AMBusiness WireVir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of ScheduleNASDAQ:VIRVir Biotechnology Inc
02/26/20246:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
02/26/20246:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
02/26/20246:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
02/26/20246:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
02/26/20243:27PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VIRVir Biotechnology Inc
02/26/20243:10PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VIRVir Biotechnology Inc
02/23/20247:05AMBusiness WireVir Biotechnology to Participate in Upcoming Investor Healthcare ConferencesNASDAQ:VIRVir Biotechnology Inc
02/22/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
02/22/20243:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
02/20/20243:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
02/20/20243:30PMBusiness WireVir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical OfficerNASDAQ:VIRVir Biotechnology Inc
02/16/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
02/13/20244:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VIRVir Biotechnology Inc
02/01/20243:05PMBusiness WireVir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024NASDAQ:VIRVir Biotechnology Inc
01/03/20241:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
12/14/20234:59AMIH Market NewsApple Stocks Reach Record, Adobe Faces Stock Drops, Berkshire Hathaway Increases Stake in OXY, and MoreNASDAQ:VIRVir Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:VIR

Your Recent History

USOTC
ASROF
Astrocast (GM)
EU
T989S
T989S
LATK
ASTUSDT
AirSwap
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved